A Comprehensive Guide to Bone Marrow Transplant Treatment

A bone marrow transplant is a process that involves harvesting cells for transplantation from the bone marrow which is the spongy tissue found in the cavities of certain bones such as the hip bones. It is also known as Stem Cell transplant. The bone marrow is rich in stem cells, which are capable of developing into various types of blood cells.

The main objective of bone marrow transplantation (BMT) is to transplant healthy bone marrow cells into a patient after the patient's unhealthy bone marrow has been treated to eliminate cancerous cells.

BMT has been used successfully in the treatment of the following diseases such as:

Aplastic anemia
Immune deficiency disorders
Adrenoleukodystrophy
Bone marrow failure syndromes
Chronic leukemia
Hemoglobinopathies
Hodgkin's lymphoma
Inborn errors of metabolism
Multiple myeloma
Myelodysplastic syndromes
Neuroblastoma
Non-Hodgkin's lymphoma
Plasma cell disorders
POEMS syndrome
Primary amyloidosis

There are two main types of bone marrow transplants (BMT), also known as stem cell transplants, based on the source of the stem cells. These are:

Autologous Transplant (AutoBMT): In an autologous transplant, the patient's stem cells are used for the transplant. Before the transplant, the patient's stem cells are collected, usually from the blood, and freeze. After high-dose chemotherapy or radiation treatment to eliminate diseased cells, the stored frozen stem cells are infused back into the patient. This type of transplant is often used in conditions like multiple myeloma or lymphoma.
Allogeneic Transplant (AlloBMT): In an allogeneic transplant, the stem cells come from a donor, typically a sibling or unrelated matched donor. Allogeneic transplants are more complex and carry a higher risk of complications, but they can offer a potentially curative treatment for diseases like leukemia, aplastic anemia, or certain genetic disorders.

During the Bone marrow Transplant, the signs and symptoms depend upon the age and overall health of the patient and the nature of the donor. The following are the symptoms:

Chest pain
Drop in blood pressure
Fever, chills, flushing
Headache
Hives
Nausea
Pain
Shortness of breath
Strange taste in the mouth

Diagnostic tests play a crucial role in evaluating a patient's eligibility for a bone marrow transplant (BMT) and monitoring their health throughout the process. Some key diagnostic tests used in the context of bone marrow transplant include:

Blood Tests: Routine blood tests assess blood cell counts and function, which can indicate the need for a transplant and track the patient's response to treatment.
Bone Marrow Aspiration and Biopsy: These tests involve the extraction of a small sample of bone marrow and a piece of bone to assess the health of the bone marrow, identify abnormalities, and determine the presence of cancer cells.
Hematopoietic Stem Cell (HSC) Collection: Tests are conducted to assess the ability to collect an adequate number of hematopoietic stem cells for transplantation, whether from the patient (autologous) or a donor (allogeneic).
Tissue Typing (HLA Typing): For allogeneic transplants, tissue typing is performed to match the human leukocyte antigens (HLA) between the donor and recipient, reducing the risk of graft-versus-host disease (GVHD).
Cytogenetic Analysis: It examines the chromosomal structure of cells, helping to identify genetic abnormalities and assess the risk of disease recurrence.
Immunological Tests: Tests may be conducted to evaluate the immune system's function and its ability to tolerate or reject the transplanted cells.
Viral and Infectious Disease Screening: Patients and donors undergo screening for viruses (such as HIV, and hepatitis) and other infectious diseases to ensure a safe transplant process.

Following a stem cell transplantation until the bone marrow can sufficiently produce blood cells, patients are at an increased risk of infections and diseases. To prevent contamination, individuals undergoing stem cell transplantation are typically placed in isolation rooms. This precautionary measure lasts for over a week or until the blood cell levels return to normal.

Isolation is more important in the case of allogeneic stem cell transplant than autologous stem cell transplant. This is the reason why some hospitals do not prefer to keep a patient who has had an autologous transplant isolated.

During the recovery phase, only one or two visitors are permitted, and those already unwell are strongly discouraged from visiting. Some hospitals offer autologous stem cell transplants on an outpatient basis, although regular follow-up visits for health monitoring are essential for a month or longer. The protective measures aim to ensure a safe and steady recuperation for patients during this critical phase of their treatment.